13-valent Pneumococcal Polysaccharide Conjugate Vaccine (TT/DT)
13-valent Pneumococcal Polysaccharide Conjugate Vaccine (TT/DT)
13-valent Pneumococcal Polysaccharide Conjugate Vaccine (TT/DT)

13-valent Pneumococcal Polysaccharide Conjugate Vaccine (TT/DT)

13-valent Pneumococcal Polysaccharide Conjugate Vaccine (TT/DT)
13-valent Pneumococcal Polysaccharide Conjugate Vaccine (TT/DT)
13-valent Pneumococcal Polysaccharide Conjugate Vaccine (TT/DT)

13-Valant Pneumococcal Polysaccharide Conjugate Vaccine (TT/DT)

In 2021, it was approved by NMPA, China.

The World's First Double vector: TT/DT(tetanus toxoid/diphtheria toxoid).                                                                       

Lower incidence of adverse events and better safety.                                                                                                       

 

【Active constituent】

Capsular polysaccharide antigen of streptococcus pneumonia serotypes 1, 5, 6A, 9V, 19A, 19F and 23F combined with tetanus toxoid, and capsular polysaccharide antigen of streptococcus pneumonia serotypes 3, 4, 6B, 7F, 14 and 18C combined with diphtheria toxoid.

【Strengths】

The vaccine is supplied in a single-dose pre filled syring with 0.5ml.

【Eligibles】

Infants and children from 6 weeks to 5 years old (before the 6th birthday).

【Shelf Life】

24 months